Table 1 Overview of variants and rationale for testing in accessory assays
From: A functional assay–based procedure to classify mismatch repair gene variants in Lynch syndrome
Gene | Protein varianta | IARC class (InSiGHT)b | Prior-P (in silico)c | MMR activity (%)d | IARC class (two-component) | Rationale for Y2H and localization testing | Binding partner interactione | Nuclear localizationf |
---|---|---|---|---|---|---|---|---|
MLH1 | Wild type | NA | NA | 100 | NA | + | + | |
p.R265S | 4 | 0.884 | 27.0 | 4 | (Likely) pathogenic | + | + | |
p.A608D | 4 | 0.9 | 37.3 | 4 | - | + | ||
p.R659L | 5 | 0.850 | 33.8 | 4 | - | - | ||
p.N64Sg | 3 | 0.718 | 51.6 | 3 | Uncertain | - | + | |
p.E268G | 1 | 0.709 | 67.0 | 3 | + | + | ||
p.A619P | 4 | 0.273 | 37.5 | 3 | - | + | ||
p.Q701K | 2 | 0.1 | 72.7 | 1 | Reduced activity in CIMRA assay | + | + | |
p.N710D | 1 | 0.1 | 60.4 | 2 | + | + | ||
p.D132H | 1 | 0.868 | 97.0 | 2 | Discordant Prior-P/CIMRA | + | + | |
p.P581L | 2 | 0.9 | 96.9 | 2 | + | + | ||
p.P603R | 2 | 0.872 | 97.0 | 2 | + | + | ||
p.K618T | 1 | 0.9 | 36.1 | 4 | Discordant InSiGHT/two component | - | + | |
p.A681T | 5 | 0.1 | 73.6 | 1 | + | + | ||
MSH2 | Wild type | NA | NA | 100 | NA | + | + | |
p.Q419K | 2 | 0.1 | 97.2 | 1 | (Likely) not pathogenic | + | + | |
p.A834T | 2 | 0.428 | 90.1 | 1 | + | + | ||
p.L93F | 4 | 0.691 | 50.5 | 3 | Uncertain | + | + | |
p.Y165D | 4 | 0.182 | 10.7 | 3 | + | - | ||
p.N331D | 2 | 0.757 | 62.4 | 3 | + | + | ||
p.R524Lg | 3 | 0.852 | 59.5 | 3 | + | + | ||
p.I577T | 2 | 0.325 | 54.8 | 3 | + | + | ||
p.P652H | 4 | 0.665 | 72.5 | 3 | + | + | ||
p.T8M | 1 | 0.1 | 60.1 | 2 | Reduced activity in CIMRA assay | + | + | |
p.R96H | 2 | 0.1 | 69.5 | 1 | + | + | ||
p.R106K | 1 | 0.1 | 80.3 | 1 | + | + |